Intuitive Machines, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual report, not a standalone fourth-quarter results filing; the supplied filing does not provide a clear Q4-only financial summary. Financial statements are audited under U.S. GAAP. The auditor gave an unqualified opinion; management reported disclosure controls and internal control over financial reporting effective at year-end and said previously identified material weaknesses were remediated.
Business context
Houston-based Intuitive Machines develops and operates space products and services, with a near-term focus on lunar access, orbital services, lunar communications and space products. It reports one operating and reportable segment. Revenue is primarily from long-term contracts, including NASA lunar missions and engineering services. The February 2023 business combination was accounted for as a reverse recapitalization.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $79.5 million | $85.9 million |
| Cost of revenue, excluding depreciation | $100.5 million | $75.5 million |
| Operating loss | $56.2 million | $5.5 million |
| Net income (loss), consolidated | $15.0 million | $(6.4) million |
| Adjusted EBITDA (non-GAAP) | $(49.6) million | $(3.8) million |
| Cash from operating activities | $(45.3) million | $0.8 million |
| Capital expenditures | $29.9 million | $16.4 million |
| Free cash flow (non-GAAP) | $(75.2) million | $(15.6) million |
Revenue declined 7%. Cost of revenue exceeded revenue by approximately $21.0 million before depreciation, versus approximately $10.4 million of positive gross contribution in 2022. The operating loss widened substantially as mission and engineering costs and public-company expenses rose. The reported consolidated net income was primarily driven by noncash fair-value gains: $66.3 million on earn-out liabilities and $15.4 million on warrant liabilities. Net income attributable to Class A common shareholders was $60.5 million, or $3.43 basic and $2.46 diluted per share; these figures reflect noncontrolling-interest allocations and preferred dividends and should not be read as operating profitability.
At December 31, 2023, cash and cash equivalents were $4.5 million and working capital was negative $51.8 million. Debt was $8.0 million, all classified as current; it was secured by substantially all company assets. The company also reported $35.4 million of total operating lease liabilities, including construction-related amounts, and $37.7 million of non-cancelable purchase commitments, $36.2 million due within 12 months. The filing states there were no off-balance-sheet arrangements.
Material changes and business developments
- Backlog increased to $268.6 million from $201.9 million. New awards included OMES III, an international payload, and the JETSON contract. The OMES III award is described as worth up to $720 million, but only funded/contracted amounts are reflected in backlog.
- Backlog is not the same as remaining performance obligations: backlog was $268.6 million, while remaining performance obligations were $57.2 million. The difference chiefly reflects constrained variable consideration and time-and-materials contracts recognized as services are performed and billed.
- One customer accounted for 74% of FY2023 revenue, down from 83% in FY2022, and 80% of year-end accounts receivable.
- All three lunar missions were in loss positions at year-end. The company recorded $30.3 million of unfavorable changes in contract losses during 2023, citing constrained mission-related variable consideration, schedule extensions, and higher labor, subcontractor, fuel-system and avionics costs.
- Capital spending rose to $29.9 million, principally for mission equipment and the new Lunar Production and Operations Center, completed in late 2023.
- The company raised $20.0 million gross in a September 2023 private placement, alongside warrants, and received other business-combination and warrant-exercise proceeds during 2023.
Outlook, risks and unusual items
- Management expected to recognize approximately 80% of year-end backlog during 2024, 3%–5% during 2025, and the balance thereafter. Management said year-end cash plus available equity facilities and subsequent transactions would fund short-term liquidity needs and the business plan for at least 12 months from the financial-statement issuance date.
- Management described IM-1 as successfully soft-landing on the Moon on February 22, 2024. IM-2 and IM-3 timing remained subject to landing-site, payload and mission planning; the filing says their launches may occur after the then-current NASA contract dates.
- In the first quarter of 2024, the company reported approximately $60.6 million of gross proceeds from warrant exercises and other equity transactions. A founder-affiliated entity contributed $10.0 million to repay a January credit-line borrowing in exchange for shares and warrants; the filing also reports conversion of 21,000 preferred shares into approximately 7.7 million Class A shares. These transactions increased liquidity but carry dilution implications.
- Key risks include mission or launch failure and delay, contract cost overruns, customer concentration, dependence on NASA and other government funding, supplier constraints, competition, continuing losses and cash use, and the need to manage growth. Government contracts may be partially funded, audited, or terminated for convenience.
- Other material considerations include potential dilution from warrants, equity awards and unit exchanges; founder control and the multi-class voting structure; related-party relationships; and a Tax Receivable Agreement requiring payment of 85% of certain realized or deemed tax savings. No material adverse outcome was expected from disclosed ordinary-course legal proceedings.
Most important facts for investors to verify
- Whether post-year-end financing proceeds provide adequate liquidity after considering operating cash burn, debt, leases, purchase commitments and planned investment.
- Actual mission schedules, costs and customer payments for IM-2 and IM-3, and whether further contract-loss provisions are required.
- Conversion of backlog into billable revenue and cash, particularly the distinction between backlog and the much smaller reported remaining performance obligations.
- Customer concentration, receivable collection and the company’s ability to diversify revenue beyond its largest customer and government contracts.
- The fully diluted share count and potential dilution from warrants, preferred-stock conversions, equity awards and exchangeable LLC units.
- Whether the reported remediation of internal-control weaknesses remains effective as the company scales and reports more complex transactions.